Undiagnosed late-onset chylothorax accompanied by fatal acute pulmonary thromboembolism after surgical treatment of lung cancer: An autopsy case and review of the literature

2010 ◽  
Vol 12 (1) ◽  
pp. 35-38 ◽  
Author(s):  
Takaki Ishikawa ◽  
Tomomi Michiue ◽  
Dong Zhao ◽  
Li Quan ◽  
Dong-Ri Li ◽  
...  
Author(s):  
Takeshi Kondo ◽  
Motonori Takahashi ◽  
Azumi Kuse ◽  
Mai Morichika ◽  
Kanako Nakagawa ◽  
...  

2019 ◽  
Vol 13 (1) ◽  
Author(s):  
Simone Sibio ◽  
Giuseppe Sigismondo Sica ◽  
Sara Di Carlo ◽  
Maurizio Cardi ◽  
Alessandra Di Giorgio ◽  
...  

2010 ◽  
Vol 24 (7) ◽  
pp. 1004-1010 ◽  
Author(s):  
Masayoshi Inoue ◽  
Masato Minami ◽  
Noriyoshi Sawabata ◽  
Yoshihisa Kadota ◽  
Yasushi Shintani ◽  
...  

2011 ◽  
Vol 25 (2) ◽  
pp. 187-193
Author(s):  
Jitian Zhang ◽  
Fengshi Chen ◽  
Takuji Fujinaga ◽  
Toru Bando ◽  
Shunitiro Niki ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (5) ◽  
pp. 998
Author(s):  
Chiara Lazzari ◽  
Aurora Mirabile ◽  
Alessandra Bulotta ◽  
Maria Grazia Viganó ◽  
Francesca Rita Ogliari ◽  
...  

Several trials have tried for decades to improve the outcome of extensive disease small cell lung cancer (ED-SCLC) through attempts to modify the standard treatments. Nevertheless, platinum/etoposide combination and topotecan have remained respectively the first and the second line standard treatments for the last 40 years. With the advent of immunotherapy, this scenario has finally changed. Our review aims to provide an overview of the primary studies on the actual therapeutic strategies available for ED-SCLC patients, and to highlight emerging evidence supporting the use of immunotherapy in SCLC patients.


The Foot ◽  
2021 ◽  
pp. 101796
Author(s):  
Elias S. Vasiliadis ◽  
Christos Vlachos ◽  
Angelos Antoniades ◽  
Eftychios Papagrigorakis ◽  
Matthaios Bakalakos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document